BLT, BENITEC BIOPHARMA LIMITED

[plastic]

Chinese New Year is over now. Next week is officially the start of Autumn. Spring in the north. Everything goes back to normal.
Just a month to go until Easter.
Things have to happen soon.

[plastic]

Personally, if its Merck we are waiting for then I have a feeling we are going to be waiting until Easter for anything to happen.

[plastic]

After leaving BLT and her options at the door SM went straight to MSB. MSB now in a trading halt pending a placement.

This might be where Merck makes itself known. They were behind the big spike all those years ago and now they're looking wounded after Covid.

We may finally have gone full circle.

[plastic]

After crawling off its lows and getting back to its original NASDAQ listing price for some reason BNTC is down 15% overnight.

Not a good look but at least its over the minimum one dollar mark.

[plastic]

[PFEs vaccine arrived in NZ the other day. Supposed to be for frontline staff and most at risk population.

Since it landed nothing else has been said.

The big slibbery slobbery sloth has market access but Merck is invisible. And nobody knows how to get their shot.

[plastic]

Long time readers might remember when Enumerate once said, the game is all about PIPEs. Private Investment into Public Equity.

Recently, I have been reading and watching YouTubes about ARK Invest and their ETF's. The CEO there says, while everyone was focused on the pre-market and IPO development phase she recognized an opportunity in the market of early stage product developers and concentrated on that.

If we assume Enumerate is right, we have to ask the question why isn't ARK active in Australian biotech scene?

Of course it could be that Enumerate was just completely wrong. That wouldn't be the first time either.

So lets see what develops. PIPE's from ARK, partnerships with MRK or reverse mergers for next gen product developers.

We shall see. Soon. Very, very soon.

[plastic]

LCT spikes because of talks with interested parties and Merck, or more correctly MSD signs a RnD deal with SPL.

That's the first time I can recall seeing a positive ID on Merck in the Au. biotech sector ever.

It could well be a harbinger of greater things to come. Especially after having sold out of their Moderna stake recently.

Perhaps they will take a piece of BNTC after having missed out last time. Might explain the price appreciation recently. Will have to be a good price if you reference their Sirna purchase
$1.3bn cash. What a mistake that turned out to be.

[plastic]

Its all very complicated regards the Covid vaccine and the main players in it. When PFE took a BLT licence all those years ago, the price went through the roof. It was a failed hostile takeover bid put up by the directors at the time. Logically, you'd deduce the perpetrator to be a PFE rival which is MRK. Indeed it was rumoured to be MRK. At the time, MRK had Bill Gates as the single largest shareholder as reported by the SMH.

Then MRNA appeared with Gates and MRK as founding partners.

Fast forward all these years to the Covid era and we find PFE and MRNA both have vaccines but MRK sold out of MRNA. That suggests to me they know somehthing which they are not happy with.

By valuation, the vaccine maker which is out of step with its peers is NVAX. Its unvervalued substantially despite its recent run up making it a takeover target.
I'm guessing, MRK or ALNY, both of which have no vaccine exposure, are sniffing around NVAX. I have no idea if NVAX IP is theirs or borrowed. If borrowed, MRK and/or ALNY are going to have to have discussions with the IP owners.

Perhaps that is why BNTC has been showing so much strength lately.

[plastic]

Opportune to say the least for some kind of announcement.

BIO CEO & Investor Digital Conference February 16-18, 2021
Accelerate Discovery. Amplify Returns.

[plastic]

In Reply To: plastic's post @ Feb 11 2021, 02:23 AM

BNTC up another 11% overnight. Nearly all of the price lost has been recovered since they redomiciled to the US while keeping the Melbourne address on all of the SEC filings. Figure that one out!